NCT01940731 - Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

March 31, 2014

Conditions

Hospital-acquired Pneumonia

Interventions

DRUG

Colistimethate sodium

3-5mg/(kg.d)(if CLcr≥80 mL/min),The maximum dose≤300mg/d 2.5-3.8mg/(kg.d)（if CLcr=50-79mL/min），The maximum dose≤230mg/d twice a day

Trial Locations (5)

The Seond Hospital of Jilin University, Jilin

Huashan Hospital ,Fudan University, Shanghai

Shanghai Tenth people's Hospital, Shanghai

Shanghai Pulmonary Hospital, Shanghai

West China Hospital ,Sichuan University, Chengdu